China Neisseria meningitidis Infections Drug Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Neisseria meningitidis Infections Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer Inc

    • Beijing Minhai Biotechnology Co Ltd

    • Griffith University

    • Serum Institute of India Ltd

    • Panacea Biotec Ltd

    • Wellstat Vaccines LLC

    • ImmunoBiology Ltd

    • MGB Biopharma Ltd

    • JN-International Medical Corp

    • Sanofi Pasteur SA

    • Biological E Ltd

    By Type:

    • MGBBP-3

    • Others

    • TP-10

    • NCL-195

    By Application:

    • Clinic

    • Hospital

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Neisseria meningitidis Infections Drug Market Overview 2018-2029

    • 1.1 China Neisseria meningitidis Infections Drug Industry Development Overview

    • 1.2 China Neisseria meningitidis Infections Drug Industry Development History

    • 1.3 China Neisseria meningitidis Infections Drug Industry Market Size (2018-2029)

    • 1.4 China Neisseria meningitidis Infections Drug Market Analysis by Type from Production Side

      • 1.4.1 China Neisseria meningitidis Infections Drug Production Volume, Production Value and Growth Rate of MGBBP-3 (2018-2029)

      • 1.4.2 China Neisseria meningitidis Infections Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Neisseria meningitidis Infections Drug Production Volume, Production Value and Growth Rate of TP-10 (2018-2029)

      • 1.4.4 China Neisseria meningitidis Infections Drug Production Volume, Production Value and Growth Rate of NCL-195 (2018-2029)

    • 1.5 China Neisseria meningitidis Infections Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Neisseria meningitidis Infections Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.2 China Neisseria meningitidis Infections Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.3 China Neisseria meningitidis Infections Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Neisseria meningitidis Infections Drug Market Analysis by Region

      • 1.6.1 North China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Neisseria meningitidis Infections Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Neisseria meningitidis Infections Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Neisseria meningitidis Infections Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Neisseria meningitidis Infections Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Neisseria meningitidis Infections Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Neisseria meningitidis Infections Drug Industry Development

    Chapter 3 Neisseria meningitidis Infections DrugIndustry Chain Analysis

    • 3.1 Neisseria meningitidis Infections Drug Industry Chain

    • 3.2 Neisseria meningitidis Infections Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Neisseria meningitidis Infections Drug Market

    • 3.3 Neisseria meningitidis Infections Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Neisseria meningitidis Infections Drug Market

    Chapter 4 China Neisseria meningitidis Infections Drug Market, by Type

    • 4.1 China Neisseria meningitidis Infections Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Neisseria meningitidis Infections Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Neisseria meningitidis Infections Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Neisseria meningitidis Infections Drug Production Volume and Growth Rate of MGBBP-3

      • 4.5.2 China Neisseria meningitidis Infections Drug Production Volume and Growth Rate of Others

      • 4.5.3 China Neisseria meningitidis Infections Drug Production Volume and Growth Rate of TP-10

      • 4.5.4 China Neisseria meningitidis Infections Drug Production Volume and Growth Rate of NCL-195

    Chapter 5 China Neisseria meningitidis Infections Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Neisseria meningitidis Infections Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Neisseria meningitidis Infections Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Neisseria meningitidis Infections Drug Market Size and Growth Rate of Clinic

      • 5.5.2 China Neisseria meningitidis Infections Drug Market Size and Growth Rate of Hospital

      • 5.5.3 China Neisseria meningitidis Infections Drug Market Size and Growth Rate of Others

    Chapter 6 China Neisseria meningitidis Infections Drug Market, by Region

    • 6.1 China Neisseria meningitidis Infections Drug Production Volume and Production Value, by Region

    • 6.2 China Neisseria meningitidis Infections Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Neisseria meningitidis Infections Drug Market Analysis

    • 7.1 North China Neisseria meningitidis Infections Drug Market, by Type

    • 7.2 North China Neisseria meningitidis Infections Drug Market, by Application

    Chapter 8 Central China Neisseria meningitidis Infections Drug Market Analysis

    • 8.1 Central China Neisseria meningitidis Infections Drug Market, by Type

    • 8.2 Central China Neisseria meningitidis Infections Drug Market, by Application

    Chapter 9 South China Neisseria meningitidis Infections Drug Market Analysis

    • 9.1 South China Neisseria meningitidis Infections Drug Market, by Type

    • 9.2 South China Neisseria meningitidis Infections Drug Market, by Application

    Chapter 10 East China Neisseria meningitidis Infections Drug Market Analysis

    • 10.1 East China Neisseria meningitidis Infections Drug Market, by Type

    • 10.2 East China Neisseria meningitidis Infections Drug Market, by Application

    Chapter 11 Northeast China Neisseria meningitidis Infections Drug Market Analysis

    • 11.1 Northeast China Neisseria meningitidis Infections Drug Market, by Type

    • 11.2 Northeast China Neisseria meningitidis Infections Drug Market, by Application

    Chapter 12 Southwest China Neisseria meningitidis Infections Drug Market Analysis

    • 12.1 Southwest China Neisseria meningitidis Infections Drug Market, by Type

    • 12.2 Southwest China Neisseria meningitidis Infections Drug Market, by Application

    Chapter 13 Northwest China Neisseria meningitidis Infections Drug Market Analysis

    • 13.1 Northwest China Neisseria meningitidis Infections Drug Market, by Type

    • 13.2 Northwest China Neisseria meningitidis Infections Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer Inc

        • 14.1.1 Pfizer Inc Company Profile

        • 14.1.2 Pfizer Inc Neisseria meningitidis Infections Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Beijing Minhai Biotechnology Co Ltd

        • 14.2.1 Beijing Minhai Biotechnology Co Ltd Company Profile

        • 14.2.2 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Griffith University

        • 14.3.1 Griffith University Company Profile

        • 14.3.2 Griffith University Neisseria meningitidis Infections Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Serum Institute of India Ltd

        • 14.4.1 Serum Institute of India Ltd Company Profile

        • 14.4.2 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Panacea Biotec Ltd

        • 14.5.1 Panacea Biotec Ltd Company Profile

        • 14.5.2 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Wellstat Vaccines LLC

        • 14.6.1 Wellstat Vaccines LLC Company Profile

        • 14.6.2 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 ImmunoBiology Ltd

        • 14.7.1 ImmunoBiology Ltd Company Profile

        • 14.7.2 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 MGB Biopharma Ltd

        • 14.8.1 MGB Biopharma Ltd Company Profile

        • 14.8.2 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 JN-International Medical Corp

        • 14.9.1 JN-International Medical Corp Company Profile

        • 14.9.2 JN-International Medical Corp Neisseria meningitidis Infections Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Sanofi Pasteur SA

        • 14.10.1 Sanofi Pasteur SA Company Profile

        • 14.10.2 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Biological E Ltd

        • 14.11.1 Biological E Ltd Company Profile

        • 14.11.2 Biological E Ltd Neisseria meningitidis Infections Drug Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Neisseria meningitidis Infections Drug Industry Research Conclusions

    • 15.2 Neisseria meningitidis Infections Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Neisseria meningitidis Infections Drug Industry Market Size (2018-2029)

    • Figure China Neisseria meningitidis Infections Drug Production Volume, Production Value and Growth Rate of MGBBP-3 (2018-2029)

    • Figure China Neisseria meningitidis Infections Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Neisseria meningitidis Infections Drug Production Volume, Production Value and Growth Rate of TP-10 (2018-2029)

    • Figure China Neisseria meningitidis Infections Drug Production Volume, Production Value and Growth Rate of NCL-195 (2018-2029)

    • Figure China Neisseria meningitidis Infections Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Neisseria meningitidis Infections Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Neisseria meningitidis Infections Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Neisseria meningitidis Infections Drug Market Size and Growth Rate from 2018-2029

    • Figure Neisseria meningitidis Infections Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Neisseria meningitidis Infections Drug Market Share by Type in 2018

    • Figure China Neisseria meningitidis Infections Drug Market Share by Type in 2023

    • Figure China Neisseria meningitidis Infections Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Neisseria meningitidis Infections Drug Production Volume and Growth Rate of MGBBP-3 (2018-2023)

    • Figure China Neisseria meningitidis Infections Drug Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Neisseria meningitidis Infections Drug Production Volume and Growth Rate of TP-10 (2018-2023)

    • Figure China Neisseria meningitidis Infections Drug Production Volume and Growth Rate of NCL-195 (2018-2023)

    • Figure China Neisseria meningitidis Infections Drug Market Share by Application in 2018

    • Figure China Neisseria meningitidis Infections Drug Market Share by Application in 2023

    • Figure China Neisseria meningitidis Infections Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Neisseria meningitidis Infections Drug Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Neisseria meningitidis Infections Drug Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Neisseria meningitidis Infections Drug Market Size and Growth Rate of Others (2018-2023)

    • Table China Neisseria meningitidis Infections Drug Production Volume by Region (2018-2023)

    • Table China Neisseria meningitidis Infections Drug Production Volume Share by Region (2018-2023)

    • Figure China Neisseria meningitidis Infections Drug Production Volume Share by Region (2018-2023)

    • Table China Neisseria meningitidis Infections Drug Production Value by Region (2018-2023)

    • Table China Neisseria meningitidis Infections Drug Production Value Share by Region (2018-2023)

    • Figure China Neisseria meningitidis Infections Drug Production Value Share by Region (2018-2023)

    • Table China Neisseria meningitidis Infections Drug Sales Volume by Region (2018-2023)

    • Table China Neisseria meningitidis Infections Drug Sales Volume Share by Region (2018-2023)

    • Figure China Neisseria meningitidis Infections Drug Sales Volume Share by Region (2018-2023)

    • Table China Neisseria meningitidis Infections Drug Sales Value by Region (2018-2023)

    • Table China Neisseria meningitidis Infections Drug Sales Value Share by Region (2018-2023)

    • Figure China Neisseria meningitidis Infections Drug Sales Value Share by Region (2018-2023)

    • Table North China Neisseria meningitidis Infections Drug Production Volume by Type (2018-2023)

    • Table North China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Figure North China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Table North China Neisseria meningitidis Infections Drug Sales Volume by Application (2018-2023)

    • Table North China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Neisseria meningitidis Infections Drug Production Volume by Type (2018-2023)

    • Table Central China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Table Central China Neisseria meningitidis Infections Drug Sales Volume by Application (2018-2023)

    • Table Central China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Table South China Neisseria meningitidis Infections Drug Production Volume by Type (2018-2023)

    • Table South China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Figure South China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Table South China Neisseria meningitidis Infections Drug Sales Volume by Application (2018-2023)

    • Table South China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Table East China Neisseria meningitidis Infections Drug Production Volume by Type (2018-2023)

    • Table East China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Figure East China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Table East China Neisseria meningitidis Infections Drug Sales Volume by Application (2018-2023)

    • Table East China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Neisseria meningitidis Infections Drug Production Volume by Type (2018-2023)

    • Table Northeast China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Neisseria meningitidis Infections Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Neisseria meningitidis Infections Drug Production Volume by Type (2018-2023)

    • Table Southwest China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Neisseria meningitidis Infections Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Neisseria meningitidis Infections Drug Production Volume by Type (2018-2023)

    • Table Northwest China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Neisseria meningitidis Infections Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Neisseria meningitidis Infections Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Neisseria meningitidis Infections Drug Sales Volume Share by Application (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Neisseria meningitidis Infections Drug Revenue, Price and Gross (2018-2023)

    • Table Beijing Minhai Biotechnology Co Ltd Company Profile

    • Table Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Revenue, Price and Gross (2018-2023)

    • Table Griffith University Company Profile

    • Table Griffith University Neisseria meningitidis Infections Drug Revenue, Price and Gross (2018-2023)

    • Table Serum Institute of India Ltd Company Profile

    • Table Serum Institute of India Ltd Neisseria meningitidis Infections Drug Revenue, Price and Gross (2018-2023)

    • Table Panacea Biotec Ltd Company Profile

    • Table Panacea Biotec Ltd Neisseria meningitidis Infections Drug Revenue, Price and Gross (2018-2023)

    • Table Wellstat Vaccines LLC Company Profile

    • Table Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Revenue, Price and Gross (2018-2023)

    • Table ImmunoBiology Ltd Company Profile

    • Table ImmunoBiology Ltd Neisseria meningitidis Infections Drug Revenue, Price and Gross (2018-2023)

    • Table MGB Biopharma Ltd Company Profile

    • Table MGB Biopharma Ltd Neisseria meningitidis Infections Drug Revenue, Price and Gross (2018-2023)

    • Table JN-International Medical Corp Company Profile

    • Table JN-International Medical Corp Neisseria meningitidis Infections Drug Revenue, Price and Gross (2018-2023)

    • Table Sanofi Pasteur SA Company Profile

    • Table Sanofi Pasteur SA Neisseria meningitidis Infections Drug Revenue, Price and Gross (2018-2023)

    • Table Biological E Ltd Company Profile

    • Table Biological E Ltd Neisseria meningitidis Infections Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.